|RFx ID :||18653135|
|Tender Name :||RFP for Oncology Haematology ePatient Information System|
|Reference # :|
|Open Date :||Friday, 12 May 2017 11:00 AM (Pacific/Auckland UTC+12:00)|
|Close Date :||Friday, 30 June 2017 3:00 PM (Pacific/Auckland UTC+12:00)|
|Tender Type :||Request for Proposals (RFP)|
|Tender Coverage :||Sole Agency [?]|
|Required Pre-qualifications :||None|
|Alternate Physical Delivery Address :||Capital & Coast District Health Board Wellington Regional Hospital Riddiford Street Ward Support Block (WSB) Level D (4) Private Bag 7902 Newtown Wellington South 6021|
|Alternate Physical Fax Number :|
Wellington Blood and Cancer Centre (WBCC) provide comprehensive chemotherapy for medical oncology and haematology services for the sub-regional population of Wairarapa, Hutt Valley and Capital Coast DHB, as well as some specialist services for patients from the wider regions. . The national Faster Cancer Treatment Programme Targets and increased screening for cancer in the community will potentially increase demand on WBCC Services over and above increased treatment requirements resulting from demographic change and population growth alone.
The complexity of chemotherapy treatment requires multiple contacts for each patient during treatment that may include medical, nursing and allied health staff. Treatment and medical follow up may be provided in Wellington Blood and Cancers Services hospital clinics in the sub-region and specialist nursing support provided in the community.
Our current paper based system creates significant risk and increases workload. Charts are completed manually, reliant on the working knowledge of the SMO/RMO completing the chart of current patient status, laboratory data and potential for toxicity. Charts then require an additional manual specialist pharmacist check. Charts then move around the department and are subject to being misplaced or lost adding additional workload and risk. Cytotoxic trained nursing staff are then currently required as part of treatment protocols to manually recheck many aspects of the patient status – using several fields in MAP, as well as paper based confirmation of decisions to treat and consent – which adds further time to the patient interaction and potential for error.
An integrated oncology information system will manage all aspects of chemotherapy programme, from diagnosis through treatment and follow-up. It will provide a single database of patient data, clinical regimens, and pharmacy information.